The light heavyweight champion had ultra trace levels of this steroid Oral-Turinabol (4-chloro-18-nor-17•-hydroxymethyl,17α-methyl-5α-androst-13-en-3α-ol (M 3 ) or even DHCMT) at drug test results originating from samples collected Jan. 6 and Jan. 7, the State Athletic Commission (CSAC) supported with MMA Fighting on Friday.

The medication tests were administered by the Voluntary Anti-Doping Agency (VADA) and reported to CSAC. The results came back according to CSAC executive officer Andy Foster, and the NAC had them.

At that hearing, Jones has been awarded a third party, one-fight permit to shield his title against Anthony Smith in UFC 235 on March 2 in Las Vegas.

As has been the case with previous trace quantities of this M 3 metabolite of DHCMT found in Jones’ system, scientists have testified that this is likely exactly the same long term metabolite that Jones was already suspended 15 months for following having a July 2017 positive drug evaluation.

Like in those prior strange results, there were no parent compounds or short- or even medium-term metabolites found in Jones — just the long term M-3 metabolite, which Dr. Daniel Eichner, the lab manager at WADA-accredited SMRTL at Salt Lake City, testified Tuesday does not give Jones any performance-enhancing added benefits. Eichner has stated in a public hearing and in written claims that there is no evidence a prohibited substance was re-administered by Jones.

Since August 2018, Jones has already established this ldquo;pulsing” effect sometimes his medication tests comeback with the M 3 metabolite and they don’t. Jones was clean of this M 3 metabolite in four USADA drug tests between December 2018 and August 2018.

With the NAC wanting Jones to come for a hearing the chose to maneuver the 232 event into the Los Angeles region. As it had jurisdiction at the July 2017 case Jones had been already licensed by the commission and has been comfortable with his drug-testing situation. Foster, based on the word of Eichner along with other specialists, chose to accept Jones to confront Alexander Gustafsson in 232 on Dec. 29 at Inglewood, Calif..

Jones finished up defeating Gustafsson to regain that the light heavyweight title by third-round TKO. Back in medication tests conducted by CSAC and USADA, Jones came from their M 3 metabolite back. However, in a sample collected by VADA on weigh in day Dec. 28, the metabolite has been back. Plus it was for its Jan. 6 and Jan. seven samples.

A rise in the sophistication of analyzing — down into the picogram amount — has led to these cases showing up.

Eichner said at the hearing that scientists know the prior studies done over the M 3 metabolite were wrong and it’therefore uncertain just how much time it could be detected in someone ’s system. vice president of athlete health and performance Jeff Novitzky told MMA Fighting a week that USADA is currently dealing with this exact same situation in another fighters, one which was Grant Dawson, that has been stripped to compete.

Jones has denied taking any chemicals blatantly. He was suspended one year in 2016 for testing positive for anti-estrogen agents clomiphene and Letrozol. Jones was suspended 15 months in his USADA case in 2017. Both situations, arbitrators and USADA concluded that no prohibited medication was likely taken by Jones .

LEAVE A REPLY

Please enter your comment!
Please enter your name here